Identification and antimicrobial susceptibility of acute external otitis microorganisms

Abstracts

Otite externa aguda é a infecção do conduto auditivo externo, geralmente causada por flora polimicrobiana. OBJETIVO: Isolar, identificar e determinar a susceptibilidade antimicrobiana dos organismos causadores da otite externa (OE). MÉTODO: 27 swabs foram obtidos de 27 orelhas de pacientes portadores de OE para cultura e 22 microrganismos foram isolados para avaliação de susceptibilidade. A susceptibilidade in vitro foi obtida através do método de ágar difusão em disco e os resultados, interpretados de acordo com critérios clínico-laboratoriais padrão. RESULTADOS: 10 culturas positivas para S. aureus, 8 culturas para P.aeruginosa, 5 para P.aeruginosa e S.aureus e 4 para fungos (Candida albicans e C. krusei). Gentamicina e as quinolonas foram ativas contra todas as cepas testadas, havendo resistência significativa contra amoxicilina/clavulanato. As espécies de Candida testadas foram sensíveis à Anfotericina B, nistatina, fluconazol e clotrimazol e resistentes à miconazol. CONCLUSÃO: A otite externa aguda é uma infecção polimicrobiana, e o conhecimento apropriado da etiologia e susceptibilidade dos microrganismos irá contribuir para o uso racional de antibióticos e o sucesso do tratamento.

meios de cultura; microbiologia; otite

ORIGINAL ARTICLE

Identification and antimicrobial susceptibility of acute external otitis microorganisms

Janaina Cândida Rodrigues Nogueira^I; Margareth de Fátima F. Melo Diniz^II; Edeltrudes Oliveira Lima^III; Zilka Nandes Lima^IV

^IMsC. ENT Physician

^IIPhD; Director - Centro de Ciências da Saúde/ UFPB

^IIIPhD, Professor of Mycology - UFPB

^IVPharmacist/ Biochemist - Laboratório Hemato

Send correspondence to

SUMMARY

Acute external otitis is a polymicrobial infectious disease.

AIM: The purpose of this study was to isolate, identify and determine the Antimicrobial susceptibility of organisms causing otitis externa (OE).

METHODS: twenty-seven swabs were taken from the ears of 27 patients with OE for culture and 22 microorganisms were isolate to evaluate sensitivity. In vitro susceptibility tests were performed by agar diffusion disk and results were interpreted according to Clinical Laboratory Standards.

RESULTS: 10 Ear cultures were positive for S. aureus , 8 for P. aeruginosa, 5 for P. aeruginosa and S. aureus and 4 for fungal organisms (Candida albicans e C. Krusei). Gentamicin and quinolones were active against all bacteria tested and significant resistance to amoxicillin/clavulanate was observed. The tested species of Candida had been sensitive to amphothericin B, nystatin, fluconazole and clotrimazole and resistant to miconazole.

CONCLUSION: Acute external otitis is a polymicrobial infection and proper knowledge regarding microorganism etiology and susceptibility will contribute to rational antibiotic usage and treatment success.

Keywords: culture media, microbiology, otitis.

INTRODUCTION

Otitis externa is an inflammation on the skin of the external auditory canal, usually associated with secondary bacterial and/or fungal infection of macerated skin and subcutaneous cellular tissue. Many factors act, changing the most superficial skin layers, opening doors for infection to happen, making bacterial otitis externa the major cause of disease in the external ear¹. Systemic conditions such as anemia, low vitamin concentration in the body, endocrine disorders - especially diabetes and many forms of dermatitis such as seborrhea, psoriasis and eczema may reduce resistance to infections in the external auditory canal, causing the development of otitis externa².

To treat this disease we use ear drops with antibiotics and/or antifungal agents associated with anesthetic and/or anti-inflammatory agents, and systemic drugs are indicated should complications occur³. The goal of this study was to isolate and identify species of microbes in patients with clinical diagnosis of acute otitis externa, and the susceptibility of microorganisms to the antimicrobial drugs standardized in the antibiogram test.

MATERIALS AND METHODS

The patients were seen in public and private otorhinolaryngology medical offices. Twenty seven patients diagnosed with acute otitis externa were selected regardless of age and gender. We used Goldenber's inclusion criteria⁴, which are: a diagnosis of otitis externa, no prior treatment and intact ear drum. The patients selected had material collected from the diseased ear by means of a swab by a trained professional and the material collected was transported in Stuart's culture medium. The study was carried out following the regulatory standards and guidelines for research involving human beings, Resolution # 196/1996⁵ from the Ministry of Health and approved by the Ethics in Research Committee of the Lauro Wanderley University Hospital, protocol # 341, and the patient signed an informed consent form in order to be submitted to material collection and culture.

The cultures were randomly sent to three different labs and the in vitro susceptibility tests were carried out through the disc spread agar, and the results were interpreted following conventional clinical and laboratorial standards^6-8.

RESULTS

The patients were seen in an otorhinolaryngology ward, regardless of age and gender, and were selected through clinical diagnosis, twenty seven patients with acute otitis externa. They had material collected from their diseased ear, and this material was submitted to bacterial culture and antibiogram study. Staphylococcus aureus were seen in 10 cultures (37%), Pseudomonas aeruginosa in 8 cultures (29.6%), Pseudomonas aeruginosa and Staphylococcus aureus together were seen in 5 cultures (18.5%), and Candida fungus was found in 4 cultures, (14.9%), in all cases, they were associated to Gram positive and Gram negative bacteria. This data is shown on Figure 1.

From the twenty seven cultures obtained in the present study, we isolated eight S. aureus strains, twelve P. aeruginosa strains, one Candida albicans strain and one C. krusei strain. The results from the susceptibility test for S. aureus can be seen on Table 1, for P. aeruginosa, on Table 2; and for fungii on Table 3.

DISCUSSION

Otitis externa is one of the most commonly found diseases in otolaryngology wards, especially during the Summer time; affecting about 10% of the population⁹, regardless of gender and age¹⁰. It may be localized or diffused, acute or chronic¹¹. The most commonly found bacterial agents are P. aeruginosa and S. aureus; and as far as fungii are concerned, the agents are Aspergillus and C.albicans^2,11.

The results hereby achieved lead us to conclude that the microorganisms isolated and identified on the external auditory canal skin were P. aeruginosa and S. aureus bacteria and Candida fungii, and considering the latter, Candida krusei was also found, which is not very frequently reported as a microbial agent associated with otitis; and this data is similar to what is found in the literature¹².

Hwang et al.¹³ carried out a bacteriology study in 161 patients and they observed that Staphylococcus aureus was as frequent as Pseudomonas aeruginosa in otitis externa patients. This data rectify the findings of the present investigation, because in our study there was no statistically significant difference between P. aeruginosa and S. aureus.

Although P. aeruginosa is the most frequently found bacteria in otitis externa, the percentage of positive cultures for S. aureus was very significant in numerous papers published, establishing both agents as the main ones responsible for infections in the external ear. In the present investigation there was a subtle predominance of S. aureus in relation to P. aeruginosa, and they were found together in 18.5% of the cases, which is very similar to what is found in the literature in regards of polymicrobial flora¹².

The treatment of acute otitis externa is based on local debridement, use of ear drops with acidifying agents and/or antimicrobial agents and, in cases of intense edemas and/or purulent secretions, one would use oral anti-inflammatory and antimicrobial agents. The use of parenteral antimicrobial agents is indicated in cases of malignant otitis externa.

The most commonly used ear drops have in their formulas: antibiotics, hormonal anti-inflammatory agents and, in some products, anesthetics. The most used antibiotics are: aminoglycosides (gentamicin and neomycin), polymyxin B, chloramphenicol and quinolones (ofloxacin, ciprofloxacin).

Since the introduction of fluoroquinolones in the medical practice, in 1980, they have been successfully used in numerous infections, especially those caused by P. aeruginosa, being added to the weaponry of ear drops¹⁴.

Ofloxacin and ciprofloxacin which are available as ear drops and, ciprofloxacin, also in ophthalmic solutions, can also be used to treat the auditory canal. The greatest advantage of these agents is the absence of ototoxic effects. Despite the systemic use of fluoroquinolones be usually contraindicated in children, topical solutions are safe and efficatious¹⁴.

Gentamicin and polymyxin B were the most effective ear drops to treat acute otitis externa against P. aeruginosa, according to a study carried out by Loh et al.¹⁵, in Singapore, with 107 patients. In the present investigation, all the P. aeruginosa strains exposed to gentamicin proved to be sensitive. However, we did not test polymyxin B, since the labs were not standardized to test this drug in the antibiogram.

In assessing the susceptibility of P. aeruginosa strains taken from patients with acute otitis externa, three were sensitive and nine had intermediate sensitivity to ceftazidime, while all the 12 strains were sensitive to ciprofloxacin. Two strains were resistant and one strain had intermediate sensitivity to neomycin, we did not observe resistance to fluoroquinolones; and all the strains exposed to gentamicin were sensitive.

Chloramphenicol is also used as ear drops; however, in the present investigation the high resistance rate of P. aeruginosa towards this drug in the susceptibility test, including augmented amoxicillin, these drugs used per os for ear diseases, as first line options, especially in the treatment of otitis media, must not be considered in the oral treatment of otitis externa, according to this susceptibility study, which share the same resistance findings from other papers^11,16.

As far as S. aureus is concerned, chloramphenicol was very active, as were quinolones, fluoroquinolones, neomycin and oxacillin, and one strain was resistant to gentamicin.

There was resistance to amoxicillin; however, when associated with augmented amoxicillin, its action was satisfactory. Second and third generation cephalosporins were active against the bacteria tested, and it can be used as a treatment option. It is important to notice that because of the diversified germ flora and variable susceptibility, in the complication of otitis externa it is paramount to order an antibiogram test in order to achieve a more efficient treatment.

There have been numerous progresses in the treatment of fungal infections with systemic antifungal drugs, such as polyenes (oral nystatin and intravenous amphothericin B) and imidazole agents (miconazole - oral and IV and oral ketoconazole). Ear drops with antifungal agents, especially those with imidazole agents have excellent action in otolaryngology; however, since otitis media is usually caused by a polymicrobial flora, with fungi and bacteria together, it would be very important to use topical agents with broad spectrum¹⁷.

There are very few ear drops to treat otomycosis today in the market, usually we have to use dermatologic creams or lotions for its treatment. The present study isolated two strains of Candida, a fungus very much found in otomycosis, in all cases associated to gram positive and gram negative bacteria. Since it is usual to find a polymicrobial flora in otomycosis, it would be better to use a topical medication with antifungal and antibacterial agents, which is not very much found in clinical practice.

The Candida species found in this study were all sensitive to Amphothericin B, nystatin, fluconazole and clotrimazole and resistant to miconazole.

Otomycosis represents a small percentage of the clinical otitis externa and, in contrast with external bacterial otitis, there are not too many specific topic preparations for its treatment.

We carried out an in vitro study of the susceptibility of the fungii responsible for otomycosis and we observed a good antifungal activity of clotrimazole and nystatin. As far as nystatin is concerned, such data match the ones found in the present investigation, since the Candida species were all susceptible to these antifungal medication¹⁸.

Imidazole derivatives, miconazole and clotrimazole may be successfully used in otomycosis in topical solutions¹⁷. However, in the present investigation the two strains were resistant to miconazole and one strain had intermediate sensitivity to clotrimazole. Among imidazole derivatives, ketoconazole represents a revolutionary antifungal agent, especially against Candida albicans, besides having low toxicity¹⁷; however, in the present study it showed intermediate sensitivity.

One important finding from the present investigation was that some antibiotic agents which are part of ear drops were not tested in some antibiograms, in other words, they were not part of the laboratory routine and there were no standardizing for the antibiotic agents that were tested.

CONCLUSION

Acute otitis externa had a polymicrobial etiology, with a predominance of S. aureus, P.aeruginosa and Candida. The bacteria assessed were resistant to penicillin and augmented amoxicillin and had good sensitivity to most antifungal agents. Therefore, a better knowledge of the etiology and the susceptibility of the microorganisms responsible for the acute otitis externa contributes to the judicial use of antimicrobial agents and treatment success.

REFERENCES

• ¹
  Guatimosim MHE. "Doenças da Orelha". In: Sociedade Brasil. ORL. Tratado de Otorrinolaringologia. 1 ed., São Paulo: Editora Roca, 2002; v.2, cap.1, p. 3-20.
• ²
  Olina M, Cametti M, Guglielmetti C, Gattoni M, Leigheb G, Pia F. External otitis Recenti Prog Med 2002;93(2):104-7.
• ³
  Hungria H. Otorrinolaringologia. 6ª. ed. Rio de Janeiro: Guanabara Koogan; 1991. cap.34, p.297-301.
• ⁴
  Goldenberg D, Golz A, Netzer A, Joachims HZ. The use of otic powder in treatment of acute external otitis. Am J Otolaryngol 2002;23(3):142-7.
• ⁵
  RESOLUÇÃO 196/96 DO CONSELHO NACIONAL DE SAÚDE, Comissão Nacional de Ética em pesquisa. Normas para pesquisa envolvendo seres humanos. Série Cadernos Técnicos. Ministério da Saúde, Brasília, 2000, 138p.
• ⁶
  Konemam EW, Roberts GD. Micologia: practica de laboratório, 3ª. ed. Buenos Aires: Medica Pan Americana. 1987, 221p.
• ⁷
  Mc Faddin JF. Biochemical Tests for identification of Medical Bacteria. Baltimore: William & Wilkins Come on; 1980.
• ⁸
  Bauer AW, Kirby WM, Sherris SC, Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol 1966;36:493-6.
• ⁹
  Gradis JR, Kamerer DB. Otite externa. In: Lopes OF, Campos CAH. Tratado de Otorrinolaringologia. São Paulo: Roca; 1994, p.651-662.
• ¹⁰
  Steuer MK, Hofstädter F, Pröbster L, Beuth J, Strutz J. Are ABH antigenic determinants on human outer ear canal epithelium responsible for Pseudomonas aeruginosa infections? ORL J Otorhinolaryngol 1995;57(3):148-52.
• ¹¹
  Brook I. Treatment of otitis externa in children. Paediatr Drugs 1999;1(4):283-9.
• ¹²
  Roland PS, Stroman DW. Microbiology of acute otitis externa. Laryngoscope 2002;112(7):1166-77.
• ¹³
  Hwang JH, Chu CK, Liu TC. Changes in bacteriology of discharging ears. J Laryngol Otol 2002;116(9):686-9.
• ¹⁴
  Simpson KL, Markham A. Ofloxacin otic solution: a review of its use in the management of ear infections. Drugs 1999;58(3):509-31.
• ¹⁵
  Loh KS, Tan KK, Kumarasinghe G, Leong HK, Yeoh KH. Otitis externa: The clinical pattern in a tertiary institution in Singapore. Ann Acad Med Singapore 1998;27(2):215-8.
• ¹⁶
  Evans P. Treatment of otitis externa. Am Board Fam Pract 1999;12(1):1-7.
• ¹⁷
  Dupont B, Drouhet E. Panorama of Mycoses in Otolaryngology. Ann Otolaryngol Chir Cervicofac 1982;99(12):517-25.
• ¹⁸
  Lawrence TL, Ayers LW, Saunders WH. Drug therapy in otomycosis: an in vitro study. Laryngoscope 1978;88(11):1755-60.

Endereço para correspondência:

Janaina Cândida Rodrigues Nogueira

Gal. Bento da Gama 192 Torre

João Pessoa PB 58000-000.

Publication Dates

• Publication in this collection
  16 Oct 2008
• Date of issue
  Aug 2008

History

• Received
  31 Jan 2007
• Accepted
  15 Apr 2008